Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ITREGDIFFERENTIATION

Financiado

Cerrado

Kinetic analysis of molecular profiles during human induced regulatory T cell i...

Kinetic analysis of molecular profiles during human induced regulatory T cell iTreg differentiation an integrative study Regulatory T cells (Tregs) suppress other immune cells and, thus, are critical mediators of peripheral self-tolerance, preventing autoimmune disease but hampering tumor rejection. Therapeutic manipulations of Treg number and funct... ver más

31/12/2015

198K€

Presupuesto del proyecto: 198K€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-12-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Allo-THYTECH Development and implementation in clinical practice of the a... 173K€ Cerrado

Treg-in-GVHD Longitudinal analysis of human CD4 FOXP3 regulatory T cell... 194K€ Cerrado

SAF2013-48834-R ORIGEN, DESARROLLO, Y FUNCION IMMUNO REGULADORA DE CELULAS M... 163K€ Cerrado

RESHAPE Reshaping undesired Inflammation in challenged Tissue Homeos... 13M€ Cerrado

DISTRICT DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS 185K€ Cerrado

DCMERT The Role of Dendritic Cell Subsets in the Maintenance of Eff... 283K€ Cerrado

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 198K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Regulatory T cells (Tregs) suppress other immune cells and, thus, are critical mediators of peripheral self-tolerance, preventing autoimmune disease but hampering tumor rejection. Therapeutic manipulations of Treg number and function are therefore subject to numerous clinical investigations. First in-man trials of adoptive Treg transfer to prevent graft-versus-host disease showed very promising outcomes. Yet, the number of naturally occurring Tregs (nTregs) is minute, encouraging the complementary approach of inducing Tregs (iTregs) from naive T cell precursors. Reinforcing this concept, there are several studies in mice indicating that iTreg transfer may be superior to nTreg transfer. Moreover, iTregs are generated in vivo and ample evidence corroborates that iTregs exert non-redundant functions to maintain health. However, the molecular mechanisms governing iTreg generation in humans are incompletely understood and procedures for human iTreg generation are controversial. Here we will therefore establish and compare different protocols of human iTreg generation juxtaposed with deep molecular profiling using RNA sequencing and DNA methylation analysis. The time-dependent transcriptomic and epigenetic data, capturing molecular events during generation of iTregs, will be subject to bioinformatics analysis. Our integrative analysis will present the first global hierarchical molecular map of pathways driving human iTreg differentiation, which in addition will provide a molecular scaffold enabling deeper analyses to resolve molecular events independent and dependent of established factors. Furthermore, the biological role of novel transcripts, splice variants and epigenetic regulations will be validated biologically by gene knockdown or overexpression experiments. Our interdisciplinary analysis of the molecular mechanisms ruling human iTreg generation may have important implications for our understanding and ability to treat cancer, autoimmune and inflammatory diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores